Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Therapy and ASCT in Poor-Risk NHL
NCT00559104Phase 2Completed
- Sponsor
- City of Hope
- Start
- Oct 1998
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine, etoposide, cyclophosphamide in non-Hodgkin lymphoma (NHL), sponsored by City of Hope. Started Oct 1998; status: completed.
02
Drugs
carmustineetoposidecyclophosphamide
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00559104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559104.